{"product_id":"wipro-pharmaceuticals-life-sciences-operational-transformation","title":"Wipro - Pharmaceuticals \/ Life Sciences Operational Transformation","description":"\u003cp\u003eWipro - Pharmaceuticals \/ Life Sciences Operational Transformation\u003c\/p\u003e\n\n\u003cp\u003eWho is This Vendor Assessment For?\u003cbr\u003e\nNelsonHall’s pharmaceuticals \/ life sciences operational transformation profile on Wipro is a comprehensive assessment of Wipros offerings and capabilities, designed for:\u003cbr\u003e\n• Sourcing managers monitoring the capabilities of existing suppliers of pharmaceuticals \/ life sciences operational transformation services and identifying vendor suitability for operational transformation services RFPs\u003cbr\u003e\n• Vendor marketing, sales, and business managers looking to benchmark themselves against their peers\u003cbr\u003e\n• Financial analysts and investors specializing in the pharmaceuticals \/ life sciences services sector.\u003c\/p\u003e\n\n\u003cp\u003eKey Findings \u0026amp; Highlights\u003cbr\u003e\nWipro focuses on the entire healthcare and life sciences ecosystem comprised of patients, physicians, payors, pharmaceutical companies, providers, pharmacists, and regulatory agencies. Wipro's offerings cover the end-to-end pharmaceuticals\/life sciences value chain. Wipro brings both the partner ecosystem, in-house tools, and Wipro IPs in any engagement.\u003cbr\u003e\nTypically Wipro works with the client in the following way:\u003cbr\u003e\n• Identifies business problems together with the client\u003cbr\u003e\n• Prioritizes and selects the problems to address\u003cbr\u003e\n• Forms agile teams together with client resources\u003cbr\u003e\n• Composes the acceleration cell by innovation orchestration\u003cbr\u003e\n• Makes innovation sprints for solution creation together with start-up partners\u003cbr\u003e\n• Graduates successful experiments to innovation projects and gives feedback from any futile experiments. \u003cbr\u003e\n?\u003c\/p\u003e\n\n\u003cp\u003eScope of the Report\u003cbr\u003e\nThe report provides a comprehensive and objective analysis of Wipro’s pharmaceuticals \/ life sciences operational transformation offerings and capabilities, and market and financial strengths, including:\u003cbr\u003e\n• Identification of the company’s strategy, emphasis, and new developments\u003cbr\u003e\n• Analysis of the company’s strengths, weaknesses, and outlook\u003cbr\u003e\n• Revenue estimates\u003cbr\u003e\n• Analysis of the profile of the company’s customer base, including the company’s targeting strategy and examples of current contracts\u003cbr\u003e\n• Analysis of the company’s offerings and key service components\u003cbr\u003e\n• Analysis of the company’s delivery organization, including the location of delivery locations.\u003c\/p\u003e","brand":"Technology \u0026 Media","offers":[{"title":"January, 2022 \/ 25 Pages \/ MCW16285361","offer_id":47714908176690,"sku":null,"price":2160.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/wipro-pharmaceuticals-life-sciences-operational-transformation","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}